Event Group
Event Groups are part of the Adverse Events Module within the Results Section. They provide a way to organize and summarize adverse event data by grouping related events together.
Each Event Group typically represents a category or class of adverse events and includes statistical information such as the number of participants affected and at risk for different event types: deaths, serious events, and other events.
Event Group path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Group
Event Group
Ignite Creation Date:
2025-12-24 @ 10:18 PM
Ignite Modification Date:
2025-12-25 @ 7:51 PM
NCT ID:
NCT00560235
Group ID:
EG007
Title:
Figitumumab 30 mg/kg + Rapamycin (Phase 2)
Description:
Figitumumab 30 mg/kg IV was administered every 4 weeks (1 cycle). As optional salvage therapy for disease progression, oral rapamycin at 2 to 4 mg/day was administered in combination with figitumumab.
Deaths Number Affected:
None
Deaths Number At Risk:
None
Serious Number Affected:
16
Serious Number At Risk:
29
Other Number Affected:
29
Other Number At Risk:
29
Study:
NCT00560235
Results Section:
NCT00560235
Adverse Events Module:
NCT00560235